Peer-reviewed research published in JAMA Oncology validates the efficacy of MyProstateScore 2.0
Read Study
Patients
Personalized Prostate Cancer Risk Testing

Why Know Your Risk?

One in eight men will be diagnosed with prostate cancer during his lifetime. Prostate cancer screening is important since it can help find cancer before it becomes more difficult to treat.

Understanding your risk of prostate cancer can give you and your doctor valuable information about your health.

>75%

Most men with elevated PSA
will have a prostate biopsy negative
for clinically significant cancer.

What Does a High PSA Level Mean?

A Prostate-Specific Antigen (PSA) test is a common blood test to screen for prostate cancer. An elevated PSA can be concerning. But PSA can be elevated for many reasons aside from cancer. PSA testing is inconclusive and can leave unanswered questions.

Fewer than 25% of men with elevated PSA would have a type of prostate cancer which needs immediate treatment. The majority will show no prostate cancer, or in some cases a type that can be safely monitored.

That means more than 75% of men with elevated PSA would have a negative biopsy and could benefit from an MPS2 risk assessment.

Do you have a high PSA?

Talk to your doctor to see if MPS2 is right for you.

MyProstateScore 2.0 (MPS2)

MPS2 is a urine test clinically proven to determine your risk of prostate cancer.

MPS2 calculates a personalized risk score for prostate cancer based on genetic markers. The personalized score gives you and your doctor clear and accurate insights to help determine next steps that are best for you.

LynxDx Results Chart

Accurate, Simple Testing That Empowers You and Your Doctor to Make Informed Decisions.

You and your family deserve the next generation in prostate cancer risk prediction to support your health.

Stay Informed

We strive to provide relevant health information to help you understand your options and advocate for yourself or a loved one.

View our latest blog posts, news articles, and clinical publications.

Frequently Asked Questions

What is MyProstateScore 2.0 (MPS2)?

MPS2 is a urine test to help you better understand your risk of prostate cancer. The test measures 18 urine biomarkers to generate a report that predicts the percent likelihood that clinically significant prostate cancer is present.

Who should be screened for prostate cancer?

Men 40+ years old should consider screening for prostate cancer, depending on their racial background and family history. We recommend consulting with your doctor.

Who should get the MPS2 test?

Men with an elevated PSA level may want the MPS2 test to better understand their true risk of prostate cancer and determine the next steps in care. We recommend consulting with your doctor to determine if MPS2 is right for you.

What is PSA?

Prostate-specific antigen (PSA) is a protein produced by normal, as well as cancerous, cells of the prostate gland. A PSA test is a common blood test to screen for prostate cancer. The higher the PSA, the higher the likelihood of prostate cancer

What does an elevated PSA mean?

Although PSA is used to screen for prostate cancer, high PSA results can occur for many reasons other than prostate cancer, including an enlarged prostate gland, prostate infection, recent sexual activity, or rigorous exercise. In fact, three out of four men with an elevated PSA do not have prostate cancer. Often, an elevated PSA result will lead to additional follow-up, like biomarker testing, to help determine whether prostate cancer is present.

What is clinically significant prostate cancer?

Clinically significant prostate cancer is a type of prostate cancer for which immediate treatment is typically recommended. This is different from low-grade prostate cancer, which often does not require treatment. MPS2 predicts the likelihood that your urologist will find clinically significant prostate cancer if you have a biopsy.

What is measured in the MPS2 test?

MPS2 is a biomarker test that analyzes 18 unique gene transcripts in your urine to determine your risk of prostate cancer. Among these is the novel gene fusion T2:ERG, which is present in most men with prostate cancer and is the most specific prostate cancer biomarker available. MPS2 is the only test on the market to detect the T2:ERG gene fusion.

Do you offer payment plans?

Yes, we offer an interest-free six-month payment plan. Please contact Billing Customer Service at (844) 534-3510, 8 a.m.-8 p.m. ET, Monday through Friday, for additional information and/or to set up payment arrangements.

How can I get MPS2?

MPS2 can be ordered by your doctor’s office

What is a biomarker?

The National Cancer Institute defines a biomarker as a biological molecule found in tissue, blood, or other bodily fluids that “is a sign of a normal or abnormal process, or of a condition or disease.”

When and how will I receive my result?

Within 5–7 business days, an MPS2 report will be sent to your doctor, who will discuss the results with you at your next appointment.

How do I make a payment?

If you receive a bill, you can pay online, by phone or by mail:

Online Payment: www.personapay.com/MPS2/login

Phone: (844) 534-3510, 8 a.m.-8 p.m. ET, Monday through Friday.

Mail to: Lynx Dx, Inc.
P.O. Box 7027
Ann Arbor, MI 48107-7027

What if my insurance plan sends me a check directly for the cost of the test?

Your insurer may send a payment directly to you rather than paying Lynx Dx. If you receive a check from your insurance company for MPS2 testing, please endorse the back of the check with your signature and the words “Pay to the order of Lynx Dx” and mail the payment, along with a copy of the Explanation of Benefits (EOB) to:

Lynx Dx, Inc.
P.O. Box 7027
Ann Arbor, MI 48107-7027

Is there a cost for this test?

The cost to you depends on your insurance. Many insured patients will not pay for MPS2 or pay only a partial cost. You may receive a bill in the mail from Lynx Dx if your insurance does not cover the full cost.

How Can We Support You?

Reach out with questions or concerns. Please do not submit any clinical or personal healthcare information.

MyProstateScore 2.0 is an in-office test that must be ordered by a physician.

"*" indicates required fields

I have:
Acceptance Terms